Compare DCOM & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DCOM | CERT |
|---|---|---|
| Founded | 1864 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1996 | 2020 |
| Metric | DCOM | CERT |
|---|---|---|
| Price | $30.79 | $9.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $34.33 | $12.78 |
| AVG Volume (30 Days) | 243.2K | ★ 2.0M |
| Earning Date | 01-21-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.18 | 0.07 |
| Revenue | $340,529,000.00 | ★ $415,551,000.00 |
| Revenue This Year | $47.68 | $10.75 |
| Revenue Next Year | $22.69 | $6.32 |
| P/E Ratio | ★ $26.27 | $140.59 |
| Revenue Growth | 8.54 | ★ 11.47 |
| 52 Week Low | $23.25 | $8.03 |
| 52 Week High | $34.00 | $15.69 |
| Indicator | DCOM | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 58.57 | 55.10 |
| Support Level | $29.31 | $9.06 |
| Resistance Level | $31.18 | $9.45 |
| Average True Range (ATR) | 0.75 | 0.31 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 82.78 | 67.49 |
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.